Literature DB >> 21218346

Bovine spongiform encephalopathy, risk perceptions, and beef consumption: differences between Canada and Japan.

Violet Muringai1, Ellen Goddard.   

Abstract

This study provides an assessment of the perceived relative risk of bovine spongiform encephalopathy (BSE) in the context of other aspects of livestock production and human health issues. The factors influencing consumers' concerns regarding these issues are identified. Consumers' risk perceptions and risk attitudes about beef and poultry and the factors that influenced any reduction in beef consumption due to food safety issues or BSE are analyzed. General population internet-based survey were used to collect data in Japan (2009) and Canada (2006, 2009). BSE remains the highest ranking livestock production concern in Japan, in 2009, 9 years after the first animal with BSE was found in Japan. In Canada (2009), 6 years after the first domestic animal was found to have BSE, BSE ranked 7 out of 8 in possible livestock production concerns. Respondents in both countries who are older and female have a higher probability of being concerned about all livestock production issues. Higher levels of education in Canada are associated with a lower probability of ranking BSE as a high risk issue, while in Japan the opposite occurs. Canadian respondents have higher risk perceptions about poultry than beef and are more willing to accept the risks of eating beef than poultry (higher risk attitudes) than Japanese respondents. Together with some of the demographic variables, risk attitudes and risk perceptions have significantly influenced reductions in beef consumption due to food safety issues over the past 4 years and since consumers first heard about BSE.

Entities:  

Mesh:

Year:  2011        PMID: 21218346     DOI: 10.1080/15287394.2011.529327

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  1 in total

1.  The 2008 US beef scare episode in South Korea: analysis of an unusual public reaction.

Authors:  Hyun J Jin
Journal:  J Public Health Policy       Date:  2014-08-28       Impact factor: 2.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.